KRAS and neoplasm: In line with our human data, Krt8high KACs with increased expression of KAC and KRAS signatures were enriched in ‘reactive’, non-neoplastic regions surrounding tumours and were themselves intermediary in the transition from normal to tumour cells (Fig. 3e and Extended Data Fig. 8).